Marshall Wace’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,328
Closed -$2.35M 2859
2024
Q4
$2.35M Buy
27,328
+7,757
+40% +$717K ﹤0.01% 1369
2024
Q3
$1.92M Buy
19,571
+7,246
+59% +$703K ﹤0.01% 1381
2024
Q2
$1.14M Buy
+12,325
New +$1.12M ﹤0.01% 1629
2023
Q4
Sell
-15,878
Closed -$1.31M 2386
2023
Q3
$1.31M Sell
15,878
-4,238
-21% -$360K ﹤0.01% 1403
2023
Q2
$1.71M Buy
20,116
+6,616
+49% +$564K ﹤0.01% 1476
2023
Q1
$1.13M Buy
13,500
+6,340
+89% +$525K ﹤0.01% 1752
2022
Q4
$608K Sell
7,160
-1,817
-20% -$150K ﹤0.01% 2302
2022
Q3
$677K Buy
8,977
+5,577
+164% +$451K ﹤0.01% 2599
2022
Q2
$276K Buy
+3,400
New +$284K ﹤0.01% 3065
2022
Q1
Sell
-2,081
Closed -$187K 3667
2021
Q4
$187K Buy
+2,081
New +$180K ﹤0.01% 3182

Other funds holding IXJ

Marshall Wace's IXJ Position: Q1 2025 in Review

Marshall Wace sold out of iShares Global Healthcare ETF (IXJ) in Q1 2025, closing a stake of 27,328 shares — an estimated $2.35M sold.

Marshall Wace first reported a position in IXJ in Q4 2021 and held it in 10 quarters. The position peaked at $2.35M in Q4 2024. 266 funds tracked by Wall St. Rank hold IXJ as of Q1 2025.

  • Marshall Wace reported no remaining iShares Global Healthcare ETF position as of Q1 2025 after selling out during the quarter.
  • Marshall Wace sold 27,328 iShares Global Healthcare ETF shares in Q1 2025, an estimated $2.35M.
  • Marshall Wace first reported a position in iShares Global Healthcare ETF in Q4 2021 and held it in 10 quarters.
  • Marshall Wace's iShares Global Healthcare ETF position peaked at $2.35M in Q4 2024.
  • 266 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q1 2025.

Based on Marshall Wace's 13F filing for Q1 2025, filed 15 May 2025.